In a post hoc analysis of two phase 3 trials, researchers set out to determine the impact of sex on tofacitinib in terms of efficacy, safety, and time to discontinuation.
The US Preventive Services Task Force (USPSTF) issued a draft recommendation regarding breast cancer screening in women aged 40 years old to 74 years old.
Researchers aimed to longitudinally examine both the variability of musculoskeletal pain among individuals with breast cancer and any potential predictors for pain during the first 18 months of aromatase...
The researchers evaluated the impact of antirheumatic treatment in women who are pregnant with psoriatic arthritis and how such treatment affects pregnancy outcomes.
Women with breast cancer who are receiving dose-dense paclitaxel are more likely to experience paclitaxel-induced peripheral neuropathy (PIPN) when compared with women who receive the treatment weekly,...
As neurocognitive decline occurs in the majority of patients with breast cancer, researchers conducted a blind randomized trial to determine if aerobic exercise was an effective intervention for reducing...
